Study of immune cells and gut germs in nephrotic flare-ups
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at how immune cells and gut (microbiota) changes relate to nephrotic syndrome flare-ups, and how a treatment approach may help during active attacks. You may be able to take part if you’re currently having a flare with high protein in your urine and meet key safety rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You receive care at one of the participating hospital centers.
- Right now you have an active nephrotic flare, confirmed by urine test results (for example, very high protein in 24 hours).
- Your kidney flare meets the study’s protein level threshold (your clinician will confirm using urine tests).
- You are not currently on strong immunosuppressant medicines unless the study allows it.
- You are able to follow study visits and safety rules (for example, not pregnant and not under legal protection/guardianship).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether mycophenolate mofetil and cyclophosphamide can improve active lupus kidney inflammation by changing immune cell patterns in your blood. It may help patients whose lupus nephritis is currently active, shown by worsening urine protein and/or kidney blood tests.
This trial collects medical data and blood/urine samples from patients with minimal change disease or focal segmental glomerulosclerosis (FSGS) to better understand how the immune system damages kidney cells.
This study looks at substances in the blood of people with nephrotic syndrome, a condition that causes protein to leak into the urine. It may help doctors understand the disease better.
This study aims to improve how doctors diagnose nephrotic syndrome by using a personalized workflow. If you have nephrotic syndrome and are under 40 years old, this trial might help find the best treatment for your specific type.
This study collects medical information and samples from patients with podocytopathy—a type of autoimmune kidney disease that causes protein leakage into urine. Researchers will analyze your medical records and any blood or kidney tissue samples you've already had to better understand the disease and find better treatments.
This trial looks at how bacteria in the gut (microbiome) and substances in the body (metabonomics) relate to IgA nephropathy, a kidney condition. The goal is to understand patterns that may help explain the disease and improve future care.
Hear when a new Microbiota trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.